OPCHHealthcare · Medical Care FacilitiesThe 11 Wall Street analysts covering Option Care Health, Inc. hold a median 12-month price target of $32 — +1.2% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 92 of 100 as at 4 Nov 2026 — among the strongest tenth. Here, the model and the Street point the same way.
Consensus tells you what everyone already believes. The model scores Option Care Health, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Issuance (93): The share count has been shrinking and the company is not leaning on new borrowing.
Growth (54): Sales and profits are flat, shrinking, or growing more slowly than they were.
Size (23): Larger than most of the companies we track — more scrutinised, less often mispriced.
Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.
The bullish and bearish analyst opinions on OPCH, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits +1.2% from it.
Of the 20 most recent actions, 1 moved their price target up and 3 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 9 Oct 2026 | UBS | Downgrade | Neutral | $39 → $32 |
| 7 Oct 2026 | Barrington Research | Downgrade | Market Perform | — |
| 7 Oct 2026 | Citizens | Downgrade | Market Perform | — |
| 7 Oct 2026 | Jefferies | Downgrade | Hold | $28 → $32 |
| 7 Oct 2026 | JP Morgan | Downgrade | Neutral | $33 |
| 7 Oct 2026 | William Blair | Downgrade | Market Perform | — |
| 30 July 2026 | Deutsche Bank | Downgrade | Hold | $26 → $24 |
| 30 July 2026 | Deutsche Bank | Downgrade | Hold | — |
| 17 July 2026 | Stephens & Co. | Downgrade | Equal-Weight | $30 → $24 |
| 17 July 2026 | Stephens & Co. | Downgrade | Equal-Weight | — |
| 8 June 2026 | Goldman Sachs | Initiates | Neutral | $22 |
| 8 June 2026 | Goldman Sachs | Initiates | Neutral | — |
| 6 May 2026 | Morgan Stanley | Maintains | Overweight | — |
| 4 May 2026 | JP Morgan | Maintains | Overweight | — |
| 1 May 2026 | Barrington Research | Maintains | Outperform | — |
| 1 May 2026 | TD Cowen | Maintains | Hold | — |
| 1 May 2026 | UBS | Maintains | Buy | — |
| 16 Jan 2026 | Barrington Research | Maintains | Outperform | — |
| 13 Jan 2026 | Citizens | Reiterates | Market Outperform | — |
| 13 Jan 2026 | Morgan Stanley | Maintains | Overweight | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
OPCH appears in the Radar on the weeks it earns a place.
AI cloud capacity
MSFTAMZNGOOGLORCL
AI chips
NVDAAVGOAMDMU
AI networking and serversIn full
ANETDELLLITECRDO
Data centre power
VRTCEGGEVVST
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 4 Nov 2026, Option Care Health, Inc. returned +17.2% against +14.8% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 32% of US stocks
Cheaper than 72% of US stocks
Cheaper than 25% of US stocks
Cheaper than 25% of US stocks
Higher than 32% of US stocks
Higher than 45% of US stocks
Higher than 19% of US stocks
Higher than 56% of US stocks
Higher than 57% of US stocks
Higher than 76% of US stocks
Higher than 82% of US stocks
Higher than 1% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Option Care Health, Inc. has a market value of $4.7B and an enterprise value of $5.8B.
Revenue in the twelve months to 30 June 2026: $5.7B. The latest quarter grew 1.9% year on year.
Net income over the same four quarters: $209.6M, a 3.7% net margin.
Diluted earnings per share, trailing twelve months: $1.33.
Free cash flow in the twelve months to 30 June 2026: $303.8M.
Option Care Health, Inc. spent $328.1M on share buybacks in the twelve months to 30 June 2026.
Trailing P/E: 24.0×; forward P/E: 15.2× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 0.00%, paying out 0% of earnings.
Option Care Health, Inc. employs 8,000 people — $712K of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Option Care Health, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Option Care reported quarterly earnings of $0.49 per share, above the Zacks Consensus Estimate of $0.48. Earnings were $0.45 per share in the year-ago quarter.
Why it matters — OPCH watchers may note that quarterly earnings exceeded the cited consensus estimate and the year-ago result.
Option Care Health announced financial results for the third quarter ended September 30, 2026.
Why it matters — The announcement marks a quarterly financial update for OPCH, though the excerpt provides no results details.
Halper Sadeh LLC says it is investigating whether Option Care Health and its board are obtaining a fair price in the proposed sale to CD&R and McKesson for $32.05 per share.
Why it matters — The investigation concerns the terms of the proposed sale and shareholder interests.
Brodsky & Smith announced that it is reminding investors of an investigation involving Option Care Health, alongside investigations involving three other companies. The notice invites shareholders to contact the firm to discuss the investigation.
Why it matters — OPCH shareholders may wish to note the announced investigation and the firm’s invitation to discuss it.
Wohl & Fruchter LLP said it is investigating the fairness of the proposed sale of Option Care Health to CD&R and McKesson for $32.05 per share in cash.
Why it matters — The investigation concerns the terms of the proposed transaction, which may be relevant to OPCH shareholders following the sale.
The 11 Wall Street analysts covering Option Care Health, Inc. have a median 12-month price target of $32, with estimates ranging from $23 to $33. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 11 analysts covering Option Care Health, Inc., 0 rate it a Buy, 11 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Option Care Health, Inc. 92 out of 100 across roughly 4,600 US stocks as at 4 Nov 2026. None of this is personal advice — it does not consider your circumstances.
As at 4 Nov 2026, Option Care Health, Inc. ranks 92 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Issuance (93 of 100).
No one can know that. What the data says: the median 12-month target from 11 analysts implies +1.2% from the last close, and Ticker Nerd's factor model ranks Option Care Health, Inc. 92 out of 100 as at 4 Nov 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering Option Care Health, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for OPCH are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $23 to $33 over the next 12 months.
Option Care Health, Inc. returned +17.2% over the 12 months to 4 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.
Option Care Health Inc. is a healthcare services company that provides home and alternate site infusion therapy across the United States.
The most recent item we track (Zacks Investment Research, 4 Nov 2026): "Option Care (OPCH) Q3 Earnings and Revenues Surpass Estimates". Option Care reported quarterly earnings of $0.49 per share, above the Zacks Consensus Estimate of $0.48. Earnings were $0.45 per share in the year-ago quarter.
Option Care Health Inc. is a healthcare services company that provides home and alternate site infusion therapy across the United States. The company delivers medications and clinical support for patients who need intravenous or injectable treatments outside the hospital, including therapies for infections, immune deficiencies, chronic inflammatory disorders, nutrition support, and other acute or chronic conditions. Its services combine pharmacy coordination, nursing care, treatment monitoring, and care coordination to support patients in home settings and ambulatory infusion suites. Option Care Health works with physicians, hospitals, payers, and other referral sources to manage complex infusion regimens through a national network of pharmacies and infusion locations. The company plays an important role in post-acute care by helping shift appropriate treatment to lower-acuity settings while maintaining clinical oversight and continuity of care.
CEO Mr. John Charles Rademacher · 8,000 employees · United States · https://optioncarehealth.com
